1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Bayer Acquires Conceptus

M&A Deal Summary

Bayer Acquires Conceptus

On April 29, 2013, Bayer acquired medical products company Conceptus for 1.1B USD

Acquisition Highlights
  • This is Bayer’s 3rd transaction in the Medical Products sector.
  • This is Bayer’s 5th largest (disclosed) transaction.
  • This is Bayer’s 3rd transaction in the United States.
  • This is Bayer’s 2nd transaction in California.

M&A Deal Summary
Date 2013-04-29
Target Conceptus
Sector Medical Products
Buyer(s) Bayer
Deal Type Add-on Acquisition
Deal Value 1.1B USD

Target

Conceptus

Mountain View, California, United States
Conceptus, Inc. is dedicated to the revolutionary design, development, and marketing of innovative solutions to advance women's health. Conceptus developed the market leading Essure procedure, the first-ever non-surgical permanent birth control method. After a decade on the market, Essure remains the most effective form of permanent birth control* available worldwide.

Search 205,173 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bayer

Leverkusen, Germany
Category Company
Founded 1863
Sector Life Science
Employees98,189
Revenue 47.6B EUR (2023)
DESCRIPTION
Bayer office building in North Sydney, Australia.
Bayer office building in North Sydney, Australia.

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer was founded in 1863 and is based in Leverkusen, Germany.

DEAL STATS #
Overall 5 of 20
Sector (Medical Products) 3 of 3
Type (Add-on Acquisition) 3 of 17
State (California) 2 of 3
Country (United States) 3 of 9
Year (2013) 1 of 3
Size (of disclosed) 5 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-01-01 Currenta OHG

Leverkusen, Germany

Currenta GmbH & Co. OHG manages and operates infrastructure, energy supply, and other essential services across the chemical parks in Leverkusen, Dormagen, and Krefeld-Uerdingen, More than 70 production companies, and service providers currently enjoy the benefits of being located in Germany’s largest chemical park.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-07-01 STEIGERWALD Arzneimittelwerk

Darmstadt, Germany

STEIGERWALD Arzneimittelwerk GmbH is a developer of herbal medicines. Its product portfolio includes Iberogast™ for the treatment of functional gastrointestinal disorders and Laif™ for the treatment of mild to moderate depression.

Buy -
Mergr

Product

Company

Legal